MX2023006715A - Proceso para la preparacion de (9s)-n-[3-(6-metilpirimidin-4-il)-3 -azabiciclo[3.2.1]octan-8-il]-9-(2,3,4-trifluorofenil)-6,7,8,9-te trahidro-5h-[1,2,4]triazolo[1,5-a]azepin-2-amina y su forma solida. - Google Patents
Proceso para la preparacion de (9s)-n-[3-(6-metilpirimidin-4-il)-3 -azabiciclo[3.2.1]octan-8-il]-9-(2,3,4-trifluorofenil)-6,7,8,9-te trahidro-5h-[1,2,4]triazolo[1,5-a]azepin-2-amina y su forma solida.Info
- Publication number
- MX2023006715A MX2023006715A MX2023006715A MX2023006715A MX2023006715A MX 2023006715 A MX2023006715 A MX 2023006715A MX 2023006715 A MX2023006715 A MX 2023006715A MX 2023006715 A MX2023006715 A MX 2023006715A MX 2023006715 A MX2023006715 A MX 2023006715A
- Authority
- MX
- Mexico
- Prior art keywords
- preparation
- solid form
- azepin
- methylpyrimidin
- octan
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 239000007787 solid Chemical group 0.000 title abstract 2
- XGTZKVXMDSWEOE-XDHZZZRXSA-N (9S)-N-[3-(6-methylpyrimidin-4-yl)-3-azabicyclo[3.2.1]octan-8-yl]-9-(2,3,4-trifluorophenyl)-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[1,5-a]azepin-2-amine Chemical group CC1=CC(N(CC2CC3)CC3C2NC2=NN(CCCC[C@H]3C(C=CC(F)=C4F)=C4F)C3=N2)=NC=N1 XGTZKVXMDSWEOE-XDHZZZRXSA-N 0.000 title 1
- 208000024667 ABeta amyloidosis, Dutch type Diseases 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 208000005145 Cerebral amyloid angiopathy Diseases 0.000 abstract 1
- 201000010374 Down Syndrome Diseases 0.000 abstract 1
- 208000005314 Multi-Infarct Dementia Diseases 0.000 abstract 1
- 201000004810 Vascular dementia Diseases 0.000 abstract 1
- 210000004556 brain Anatomy 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 208000017004 dementia pugilistica Diseases 0.000 abstract 1
- 230000008021 deposition Effects 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Hospice & Palliative Care (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
La presente invención se refiere al proceso para la preparación de un compuesto (I), y su forma sólida, que es un modulador de ?-secretasa y puede ser útil para la profilaxis y el tratamiento de una enfermedad asociada al depósito de ß-amiloide en el cerebro, en particular la enfermedad de Alzheimer, y otras enfermedades, tales como angiopatía amiloide cerebral, hemorragia cerebral hereditaria con amiloidosis, tipo holandés (HCHWA-D), demencia multiinfarto, demencia pugilística y síndrome de Down.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2020135740 | 2020-12-11 | ||
| PCT/EP2021/084887 WO2022122864A1 (en) | 2020-12-11 | 2021-12-09 | Process for the preparation of (9s)-n-[3-(6-methylpyrimidin-4-yl)-3-azabicyclo[3.2.1]octan-8-yl]-9-(2,3,4-trifluorophenyl)-6,7,8,9-tetrahydro-5h-[1,2,4]triazolo[1,5-a]azepin-2-amine and its solid form |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2023006715A true MX2023006715A (es) | 2023-06-23 |
Family
ID=79092930
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2023006715A MX2023006715A (es) | 2020-12-11 | 2021-12-09 | Proceso para la preparacion de (9s)-n-[3-(6-metilpirimidin-4-il)-3 -azabiciclo[3.2.1]octan-8-il]-9-(2,3,4-trifluorofenil)-6,7,8,9-te trahidro-5h-[1,2,4]triazolo[1,5-a]azepin-2-amina y su forma solida. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20240018143A1 (es) |
| EP (1) | EP4259630A1 (es) |
| JP (1) | JP2023553051A (es) |
| KR (1) | KR20230118102A (es) |
| CN (1) | CN116685589A (es) |
| AR (1) | AR124194A1 (es) |
| AU (1) | AU2021393968A1 (es) |
| CA (1) | CA3199042A1 (es) |
| IL (1) | IL303507A (es) |
| MX (1) | MX2023006715A (es) |
| TW (1) | TW202235076A (es) |
| WO (1) | WO2022122864A1 (es) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2512840T3 (es) | 2010-01-15 | 2014-10-24 | Janssen Pharmaceuticals, Inc. | Derivados de triazol bicíclicos sustituidos novedosos como moduladores de gamma-secretasa |
| JP6980751B2 (ja) * | 2016-07-14 | 2021-12-15 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | 縮合ピリミジン誘導体 |
| AR109829A1 (es) | 2016-09-29 | 2019-01-30 | Hoffmann La Roche | Derivados de piperidina puenteados |
| AR110001A1 (es) | 2016-11-01 | 2019-02-13 | Hoffmann La Roche | Derivados heteroarilo bicíclicos |
| JP7335248B2 (ja) | 2018-01-22 | 2023-08-29 | エフ． ホフマン－ラ ロシュ アーゲー | トリアゾロ－アゼピン誘導体 |
| IL283994B2 (en) | 2018-12-27 | 2024-05-01 | Hoffmann La Roche | Process for preparing exo-tert-butyl N-(3-azabicyclo[3.2.1]octane-8-YL)carbamate |
| JP2023503509A (ja) * | 2019-11-29 | 2023-01-30 | エフ．ホフマン－ラ ロシュ アーゲー | （９Ｓ）－２－ブロモ－９－（２，３，４－トリフルオロフェニル）－６，７，８，９－テトラヒドロ－５Ｈ－［１，２，４］トリアゾロ［１，５－ａ］アゼピンの製造方法 |
-
2021
- 2021-12-09 MX MX2023006715A patent/MX2023006715A/es unknown
- 2021-12-09 AU AU2021393968A patent/AU2021393968A1/en active Pending
- 2021-12-09 KR KR1020237019521A patent/KR20230118102A/ko unknown
- 2021-12-09 IL IL303507A patent/IL303507A/en unknown
- 2021-12-09 AR ARP210103410A patent/AR124194A1/es unknown
- 2021-12-09 EP EP21831292.4A patent/EP4259630A1/en active Pending
- 2021-12-09 CA CA3199042A patent/CA3199042A1/en active Pending
- 2021-12-09 JP JP2023534366A patent/JP2023553051A/ja active Pending
- 2021-12-09 CN CN202180078465.7A patent/CN116685589A/zh active Pending
- 2021-12-09 WO PCT/EP2021/084887 patent/WO2022122864A1/en active Application Filing
- 2021-12-10 TW TW110146264A patent/TW202235076A/zh unknown
-
2023
- 2023-06-08 US US18/331,792 patent/US20240018143A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR20230118102A (ko) | 2023-08-10 |
| CA3199042A1 (en) | 2022-06-16 |
| US20240018143A1 (en) | 2024-01-18 |
| EP4259630A1 (en) | 2023-10-18 |
| WO2022122864A1 (en) | 2022-06-16 |
| TW202235076A (zh) | 2022-09-16 |
| JP2023553051A (ja) | 2023-12-20 |
| CN116685589A (zh) | 2023-09-01 |
| AR124194A1 (es) | 2023-02-22 |
| IL303507A (en) | 2023-08-01 |
| AU2021393968A1 (en) | 2023-05-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ751418A (en) | Crystalline form of (s)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra-hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereof | |
| NO20081523L (no) | Fremstilling og anvendelse av tetrahydropyrrolo(3,2-C)Pyridin-4-on-derivater for behandling av fedme, psykiatriske og neurologiske forstyrrelser | |
| EA201190303A1 (ru) | ПРОИЗВОДНЫЕ 1,2,4-ТРИАЗОЛО[4,3-а]ПИРИДИНА И ИХ ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ ИЛИ ПРЕДУПРЕЖДЕНИЯ НЕВРОЛОГИЧЕСКИХ И ПСИХИАТРИЧЕСКИХ РАССТРОЙСТВ | |
| MY152386A (en) | Substituted 6a,7,8,9-tetrahydropyrido[3,2-e] pyrrolo[1,2-a]pyrazin-6(5h)-ones | |
| CA2887598A1 (en) | Cyclopropanamine compound and use thereof | |
| TN2015000169A1 (en) | Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use | |
| EA201190301A1 (ru) | ПРОИЗВОДНЫЕ 1,2,4-ТРИАЗОЛО[4,3-а]ПИРИДИНА И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ПОЛОЖИТЕЛЬНЫХ АЛЛОСТЕРИЧЕСКИХ МОДУЛЯТОРОВ РЕЦЕПТОРОВ mGluR2 | |
| UA109800C2 (xx) | ПОХІДНІ 6,7-ДИГІДРОПІРАЗОЛО$1,5-a]ПІРАЗИН-4-ІЛАМІНУ, КОРИСНІ ЯК ІНГІБІТОРИ БЕТА-СЕКРЕТАЗИ (BACE) | |
| NZ595945A (en) | 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors | |
| WO2007120752A3 (en) | 4, 5-dihydro- [1, 2, 4] triazolo [4, 3-f] pteridines as protein kinase plk1 inhibitors for the treatment of proliferative disorders | |
| BR112017022568A2 (pt) | compostos e seus usos como inibidores de bace1 | |
| RU2010140613A (ru) | Амиды диазабициклоалканов, селективные в отношении подтипа никотиновых ацетилхолиновых рецепторов | |
| JOP20200073A1 (ar) | مركبات أميد إيميدازوبيريدين تحمل بدائل واستخداماتها | |
| CR20220536A (es) | Aminotiazoles sustituidos como inhibidores de dgkzeta para la activación inmune | |
| WO2015161830A1 (en) | Heteroaromatic derivatives and pharmaceutical applications thereof | |
| JP2019528319A (ja) | 疾患の処置のための二重ロイシンジッパー（ｄｌｋ）キナーゼの阻害薬 | |
| JOP20170113B1 (ar) | مركبات 5، 6، 7، 8-رباعي هيدرو [1، 2، 4] تريازولو [4، 3-أ] بيريدين 3(2h)-ون مستبدلة ومركبات 2، 5، 6، 7-رباعي هيدرو-3h-بيرولو [2، 1-ج] [1، 2، 4] تريازول-3-ون واستخداماتها | |
| BR112015000459A8 (pt) | Inibidores da enzima fosfodiesterase 10, seu uso, composição farmacêutica que os compreende, seus processo de preparação e produto | |
| MX2023006715A (es) | Proceso para la preparacion de (9s)-n-[3-(6-metilpirimidin-4-il)-3 -azabiciclo[3.2.1]octan-8-il]-9-(2,3,4-trifluorofenil)-6,7,8,9-te trahidro-5h-[1,2,4]triazolo[1,5-a]azepin-2-amina y su forma solida. | |
| JOP20220034A1 (ar) | مركبات [1، 2، 4] تريازولو [1، 5-جـ] كوينازولين-5-أمين | |
| PH12020551779A1 (en) | Spiropiperidine allosteric modulators of nicotinic acetylcholine receptors | |
| AR081389A1 (es) | Sal de tipo hemifumarato, composicion farmaceutica y proceso de obtencion de la misma. | |
| MA42988B1 (fr) | Dérivés d'éther spirocycliques de pyrazolo [1,5-a] pyrimidine-3-carboxamide | |
| NZ597613A (en) | 5-ht3 receptor modulators, methods of making, and use thereof | |
| MX2021006955A (es) | Proceso para la preparacion de n-(3-azabiciclo[3.2.1]octan-8-il)ca rbamato de exo-terc-butilo. |